SELENIUM CONCENTRATIONS IN THE HUMAN THYROID-GLAND

被引:50
作者
AASETH, J
FREY, H
GLATTRE, E
NORHEIM, G
RINGSTAD, J
THOMASSEN, Y
机构
[1] NORWEGIAN CANC REGISTRY,OSLO,NORWAY
[2] UNIV HOSP TROMSO,DEPT OCCUPAT MED,N-9012 TROMSO,NORWAY
[3] AKER HOSP,DEPT MED,OSLO 5,NORWAY
[4] NATL VET INST,OSLO 1,NORWAY
[5] NATL INST OCCUPAT HLTH,OSLO,NORWAY
关键词
carcinogenesis; liver; Selenium; thyroid gland;
D O I
10.1007/BF02917202
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Recently, we found that prediagnostic serum selenium concentration was significantly lower for cases developing thyroid cancer (n=43) than for controls. We assumed that redistribution of serum selenium into the affected tissue took place in the prediagnostic period. The present study was carried out to determine the physiological concentration of selenium in the thyroid, since very few data are available in the literature. The concentrations of selenium in the thyroid (n=45) and liver samples from Norwegians who had died because of acute illness or accidents were determined by hydride generation atomic absorption spectrometry. The mean selenium concentration was found to be 0.72±0.44 μg/g in the thyroid and 0.45±0.11 μg/g in the liver tissue. The surprisingly high concentration of selenium in apparently normal thyroids indicates that selenium has important functions in this organ. The remarkably broad range, together with the observation that no significant correlation exists between thyroid and liver concentrations, suggest that factors other than the selenium status are important determinants for the selenium concentration in the thyroid gland. This observation is consistent with our hypothesis that in carcinogenesis, prediagnostic processes influence the serum-/thyroid-ratio of selenium. © 1990 The Humana Press Inc.
引用
收藏
页码:147 / 152
页数:6
相关论文
共 26 条
[1]  
AASETH J, 1988, SELENIUM MED BIOL
[2]   INHIBITION OF HEPATIC DEIODINATION OF THYROXINE IS CAUSED BY SELENIUM DEFICIENCY IN RATS [J].
BECKETT, GJ ;
BEDDOWS, SE ;
MORRICE, PC ;
NICOL, F ;
ARTHUR, JR .
BIOCHEMICAL JOURNAL, 1987, 248 (02) :443-447
[3]   EVIDENCE FOR SPECIFIC SELENIUM TARGET TISSUES AND NEW BIOLOGICALLY IMPORTANT SELENOPROTEINS [J].
BEHNE, D ;
HILMERT, H ;
SCHEID, S ;
GESSNER, H ;
ELGER, W .
BIOCHIMICA ET BIOPHYSICA ACTA, 1988, 966 (01) :12-21
[4]   SELENIUM-DEPENDENT AND NON-SELENIUM-DEPENDENT GLUTATHIONE PEROXIDASES IN HUMAN-TISSUE EXTRACTS [J].
CARMAGNOL, F ;
SINET, PM ;
JEROME, H .
BIOCHIMICA ET BIOPHYSICA ACTA, 1983, 759 (1-2) :49-57
[5]   BIOSYNTHESIS OF THYROID-HORMONE - BASIC AND CLINICAL ASPECTS [J].
DEGROOT, LJ ;
NIEPOMNISZCZE, H .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1977, 26 (06) :665-718
[6]   SELENIUM IN BLOOD AND HUMAN TISSUES [J].
DICKSON, RC ;
TOMLINSON, RH .
CLINICA CHIMICA ACTA, 1967, 16 (02) :311-+
[7]   KINETICS OF GLUTATHIONE PEROXIDASE [J].
FLOHE, L ;
BRAND, I .
BIOCHIMICA ET BIOPHYSICA ACTA, 1969, 191 (03) :541-&
[8]   PREDIAGNOSTIC SERUM SELENIUM IN A CASE-CONTROL STUDY OF THYROID-CANCER [J].
GLATTRE, E ;
THOMASSEN, Y ;
THORESEN, SO ;
HALDORSEN, T ;
LUNDLARSEN, PG ;
THEODORSEN, L ;
AASETH, J .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1989, 18 (01) :45-49
[9]   SELENIUM DEFICIENCY AS A POSSIBLE FACTOR IN THE PATHOGENESIS OF MYXOEDEMATOUS ENDEMIC CRETINISM [J].
GOYENS, P ;
GOLDSTEIN, J ;
NSOMBOLA, B ;
VIS, H ;
DUMONT, JE .
ACTA ENDOCRINOLOGICA, 1987, 114 (04) :497-502
[10]  
HAUGEN A, 1985, 10TH NORD AT ABS SPE, P50